Table of Contents

Interaction of nNOS with PSD-95 Negatively Controls Regenerative Repair after Stroke

  1. Dong-Ya Zhu1,2,3
  1. 1Laboratory of Cerebrovascular Disease,
  2. 2Institution of Stem Cells and Neuroregeneration, and
  3. 3Departments of Pharmacology and
  4. 4Medicinal Chemistry, School of Pharmacy, Nanjing Medical University, Nanjing 210029, People's Republic of China
  1. Author contributions: C.-X.L. and D.-Y.Z. designed research; C.-X.L., Y.-H.L., X.-D.Q., Y.T., H.-H.Z., X.J., H.-Y.N., F.-Y.Z., C.Q., F.L., H.-Y.W., and L.C. performed research; Y.Z. contributed unpublished reagents/analytic tools; C.X.L. analyzed data; D.-Y.Z. wrote the paper.

Abstract

Stroke is a major public health concern. The lack of effective therapies heightens the need for new therapeutic targets. Mammalian brain has the ability to rewire itself to restore lost functionalities. Promoting regenerative repair, including neurogenesis and dendritic remodeling, may offer a new therapeutic strategy for the treatment of stroke. Here, we report that interaction of neuronal nitric oxide synthase (nNOS) with the protein postsynaptic density-95 (PSD-95) negatively controls regenerative repair after stroke in rats. Dissociating nNOS–PSD-95 coupling in neurons promotes neuronal differentiation of neural stem cells (NSCs), facilitates the migration of newborn cells into the injured area, and enhances neurite growth of newborn neurons and dendritic spine formation of mature neurons in the ischemic brain of rats. More importantly, blocking nNOS–PSD-95 binding during the recovery stage improves stroke outcome via the promotion of regenerative repair in rats. Histone deacetylase 2 in NSCs may mediate the role of nNOS–PSD-95 association. Thus, nNOS–PSD-95 can serve as a target for regenerative repair after stroke.

  • Received April 1, 2014.
  • Revision received August 22, 2014.
  • Accepted August 28, 2014.